Monovisc is a ready-to-use, pre-filled syringe designed for the single-injection treatment of osteoarthritis (OA). It is a sterile, non-animal derived hyaluronic acid solution intended for intra-articular injection. Monovisc helps reduce joint pain and improve mobility by restoring the viscoelastic properties of synovial fluid, offering a well-tolerated alternative to long-term use of systemic pain medication.
The formulation is designed to provide prolonged symptom relief with one injection, supporting joint lubrication and cushioning while reducing mechanical stress within the joint.
Monovisc acts directly within the affected joint to improve its biomechanical function.
Main effects include:
- reduction of joint pain associated with osteoarthritis
- improvement of joint mobility and flexibility
- enhanced lubrication and shock absorption within the joint
- support of joint function with a single intra-articular injection
Symptom relief may be noticeable shortly after administration and can last for several months, depending on the individual condition and severity of osteoarthritis.